Development and Validation of an MRI-Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients

被引:0
作者
Liu, Wen-Qi [1 ,2 ]
Xue, Yu-Ting [1 ,2 ]
Huang, Xu-Yun [1 ,2 ]
Lin, Bin [1 ,2 ]
Li, Xiao-Dong [1 ,2 ]
Ke, Zhi-Bin [1 ,2 ]
Chen, Dong-Ning [1 ,2 ]
Chen, Jia-Yin [1 ,2 ]
Wei, Yong [1 ,2 ]
Zheng, Qing-Shui [1 ,2 ]
Xue, Xue-Yi [1 ,2 ,3 ]
Xu, Ning [1 ,2 ,3 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Dept Urol, Fuzhou, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Natl Reg Med Ctr, Dept Urol, Binhai Campus, Fuzhou, Peoples R China
[3] Fujian Med Univ, Affiliated Hosp 1, Fujian Key Lab Precis Med Canc, Fuzhou, Peoples R China
关键词
nomogram; oligometastatic prostate cancer (PCa); overall survival (OS); radiomics; STEREOTACTIC BODY RADIOTHERAPY; 2014 INTERNATIONAL SOCIETY; ANDROGEN DEPRIVATION; COMBINATION; SURVIVAL; BRACHYTHERAPY; PROGRESSION; NEUTROPHILS; SYSTEM;
D O I
10.1002/cam4.70481
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveWe aimed to develop and validate a nomogram based on MRI radiomics to predict overall survival (OS) for patients with de novo oligometastatic prostate cancer (PCa).MethodsA total of 165 patients with de novo oligometastatic PCa were included in the study (training cohort, n = 115; validating cohort, n = 50). Among them, MRI scans were conducted and T2-weighted imaging (T2WI) and apparent diffusion coefficient (ADC) sequences were collected for radiomics features along with their clinicopathological features. Radiological features were extracted from T2WI and ADC sequences for prostate tumors. Univariate Cox regression analysis and the least absolute shrinkage and selection operator (LASSO) combined with 10-fold cross-validation were used to select the optimal features on each sequence. Then, a weighted radiomics score (Rad-score) was generated and independent risk factors were obtained from univariate and multivariate Cox regressions to build the nomogram. Model performance was assessed using receiver operating characteristic (ROC) curves, calibration, and decision curve analysis (DCA).ResultsEastern Cooperative Oncology Group (ECOG) score, absolute neutrophil count (ANC) and Rad-score were included in the nomogram as independent risk factors for OS in de novo oligometastatic PCa patients. We found that the areas under the curves (AUCs) in the training cohort were 0.734, 0.851, and 0.773 for predicting OS at 1, 2, and 3 years, respectively. In the validating cohort, the AUCs were 0.703, 0.799, and 0.833 for predicting OS at 1, 2, and 3 years, respectively. Furthermore, the clinical relevance of the predictive nomogram was confirmed through the analysis of DCA and calibration curve analysis.ConclusionThe MRI-based nomogram incorporating Rad-score and clinical data was developed to guide the OS assessment of oligometastatic PCa. This helps in understanding the prognosis and improves the shared decision-making process.
引用
收藏
页数:15
相关论文
共 65 条
[1]  
Ahmed KA, 2012, FRONT ONCOL, V2, DOI [10.3389/fonc.2012.00215, 10.3389/fonc.2012.00172]
[2]   Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer [J].
Armstrong, Andrew J. ;
Azad, Arun A. ;
Iguchi, Taro ;
Szmulewitz, Russell Z. ;
Petrylak, Daniel P. ;
Holzbeierlein, Jeffrey ;
Villers, Arnauld ;
Alcaraz, Antonio ;
Alekseev, Boris ;
Shore, Neal D. ;
Gomez-Veiga, Francisco ;
Rosbrook, Brad ;
Zohren, Fabian ;
Yamada, Shunsuke ;
Haas, Gabriel P. ;
Stenzl, Arnulf .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (15) :1616-+
[3]   ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer [J].
Armstrong, Andrew J. ;
Szmulewitz, Russell Z. ;
Petrylak, Daniel P. ;
Holzbeierlein, Jeffrey ;
Villers, Arnauld ;
Azad, Arun ;
Alcaraz, Antonio ;
Alekseev, Boris ;
Iguchi, Taro ;
Shore, Neal D. ;
Rosbrook, Brad ;
Sugg, Jennifer ;
Baron, Benoit ;
Chen, Lucy ;
Stenzl, Arnulf .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (32) :2974-+
[4]   Neutrophil count is associated with survival in localized prostate cancer [J].
Bahig, Houda ;
Taussky, Daniel ;
Delouya, Guila ;
Nadiri, Amal ;
Gagnon-Jacques, Ariane ;
Bodson-Clermont, Paule ;
Soulieres, Denis .
BMC CANCER, 2015, 15
[5]   Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or ... [J].
Barata, Pedro C. ;
Sartor, A. Oliver .
CANCER, 2019, 125 (11) :1777-1788
[6]   ESUR prostate MR guidelines 2012 [J].
Barentsz, Jelle O. ;
Richenberg, Jonathan ;
Clements, Richard ;
Choyke, Peter ;
Verma, Sadhna ;
Villeirs, Geert ;
Rouviere, Olivier ;
Logager, Vibeke ;
Futterer, Jurgen J. .
EUROPEAN RADIOLOGY, 2012, 22 (04) :746-757
[7]   Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy [J].
Berkovic, Patrick ;
De Meerleer, Gert ;
Delrue, Louke ;
Lambert, Bieke ;
Fonteyne, Valerie ;
Lumen, Nicolaas ;
Decaestecker, Karel ;
Villeirs, Geert ;
Vuye, Philippe ;
Ost, Piet .
CLINICAL GENITOURINARY CANCER, 2013, 11 (01) :27-32
[8]   The role of opioids in cancer response to immunotherapy [J].
Botticelli, Andrea ;
Cirillo, Alessio ;
Pomati, Giulia ;
Cerbelli, Bruna ;
Scagnoli, Simone ;
Roberto, Michela ;
Gelibter, Alain ;
Mammone, Giulia ;
Calandrella, Maria Letizia ;
Cerbelli, Edoardo ;
Di Pietro, Francesca Romana ;
De Galitiis, Federica ;
Lanzetta, Gaetano ;
Cortesi, Enrico ;
Mezi, Silvia ;
Marchetti, Paolo .
JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
[9]   Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer [J].
Chaddad, Ahmad ;
Kucharczyk, Michael J. ;
Niazi, Tamim .
CANCERS, 2018, 10 (08)
[10]   Short-term therapeutic outcomes of robotic-assisted laparoscopic radical prostatectomy for oligometastatic prostate cancer: a propensity score matching study [J].
Chen, Huan ;
Qu, Min ;
Lian, Bi-Jun ;
Wang, Hai-Feng ;
Wang, Yan ;
Dong, Zhen-Yang ;
Zhu, Feng ;
Shi, Zhen-Kai ;
Jia, Ze-Peng ;
Sun, Ying-Hao ;
Gao, Xu .
CHINESE MEDICAL JOURNAL, 2020, 133 (02) :127-133